Plenary Session – The Bioethics Associated with Expanded Access / Early Access

This panel will address questions as to why some companies actually implement expanded access or named patient programs for specific small groups or individuals and some companies do not. Panel will discuss what ethical issues companies must wrestle with to ensure they are doing the best for expanded access patients. The panel will be composed of a diverse representation from EAP and NPP supply chain and advocacy groups.